Approved indications
Sutab is approved as an osmotic laxative to cleanse the colon in preparation for colonoscopy in adults.

Off-label uses
Off-label use is limited; some clinicians may consider sulfate-based tablet regimens for bowel preparation before other lower–gastrointestinal procedures, but Sutab has been specifically studied and labeled only for colonoscopy.

Efficacy expectations
In clinical trials, most adults achieved adequate or excellent colon cleansing with Sutab, with frequent liquid bowel movements starting within a few hours of the first dose and the colon typically clear by the time of colonoscopy; its cleansing effectiveness is comparable to or slightly better than standard large-volume polyethylene glycol (PEG) liquid preparations, while offering a tablet option that some patients find easier to take, though it still requires drinking substantial amounts of water.

Typical dosing and timing
For adults, the recommended regimen is a split dose of 24 tablets: 12 tablets with water in the evening before colonoscopy and 12 tablets with water 5 to 8 hours before the procedure, with all tablets and required clear liquids finished at least 2 hours before the exam.

How to take the medicine
On the day before colonoscopy, you may have a low-residue breakfast, then only clear liquids; in the evening and again the next morning, swallow each tablet with a sip of water until 12 tablets are taken with 16 ounces of water, then drink two more 16-ounce containers of water over the next 1½ hours, avoiding milk, alcohol, and red or purple liquids and not using other laxatives.

Special dosing instructions
Most other oral medicines should be taken at least 1 hour before starting each Sutab dose, and certain drugs (such as tetracycline or fluoroquinolone antibiotics, iron products, digoxin, chlorpromazine, and penicillamine) should be taken at least 2 hours before and not less than 6 hours after each dose; your endoscopy team may adjust the exact timing to fit your procedure schedule.

Missed dose and overdose guidance
If you miss part of a dose or cannot finish all the tablets or water, contact your endoscopy team promptly for instructions because incomplete preparation may lead to a poor-quality colonoscopy; taking more than prescribed can cause severe diarrhea, dehydration, electrolyte disturbances, kidney problems, or heart rhythm changes and requires urgent medical attention and guidance from emergency services or a poison control center.

Common side effects
Very common effects during preparation include frequent loose or watery stools, urgency, nausea, abdominal bloating or cramping, vomiting, abdominal pain, and headache; these usually begin within a few hours of starting Sutab and generally resolve after the colonoscopy.

Serious or rare adverse effects
Serious problems are uncommon but can include severe dehydration and fluid or electrolyte imbalances (which may lead to kidney injury, low blood pressure, abnormal heart rhythms, or seizures), worsening of heart failure, ischemic colitis or other bowel injury, and severe allergic reactions such as rash, hives, swelling of the face or throat, or trouble breathing, all of which require immediate medical attention.

Warnings and precautions
Sutab must not be used in people with known or suspected gastrointestinal obstruction or ileus, bowel perforation, toxic colitis, toxic megacolon, gastric retention, or a prior serious hypersensitivity to its ingredients; it should be used with caution and close medical guidance in adults who are elderly or frail or who have kidney disease, heart disease (including arrhythmias or heart failure), liver disease, a history of seizures, electrolyte disturbances, or are taking diuretics, ACE inhibitors, ARBs, NSAIDs, lithium, or other drugs that affect fluid and electrolyte balance. It is approved only for adults, and in pregnancy or breastfeeding clinicians weigh the need for colonoscopy and prep against limited safety data.

Safety compared with other bowel preps
When taken exactly as directed with adequate hydration, Sutab’s overall safety profile is similar to other modern bowel preparations, with the primary risks related to short-term fluid shifts, dehydration, and electrolyte changes rather than long-term toxicity.

Reporting and updates
Side effects can be reported to the manufacturer at the phone number on the package or to the U.S. Food and Drug Administration (FDA) through the MedWatch program online or by calling 1-800-FDA-1088, where updated safety information and safety communications are also available.

Drug interactions
Sutab can interact with medicines that affect fluid and electrolyte balance or kidney function, such as diuretics, ACE inhibitors, ARBs, NSAIDs, and lithium, and it can reduce absorption of some oral drugs because of rapid bowel transit, so most medicines should be taken at least 1 hour before each Sutab dose and certain drugs (including tetracycline or fluoroquinolone antibiotics, iron products, digoxin, chlorpromazine, and penicillamine) should be separated by at least 2 hours before and 6 hours after each dose.

Food, drink, and other products
During preparation you should avoid alcohol, milk, and red or purple liquids, not use other laxatives, and review over-the-counter medicines and supplements (such as herbal products, electrolyte drinks, and antacids) with your clinician to be sure they are safe with Sutab and your medical conditions.

Conditions and co-medications requiring caution
Extra precautions and individualized plans are important if you have kidney disease, heart failure, a history of heart rhythm problems or low blood pressure, advanced liver disease, inflammatory bowel disease, difficulty swallowing, or a history of seizures or low sodium, or if you are elderly or on multiple medicines that influence fluid balance or the QT interval.

Monitoring needs
For higher-risk patients, clinicians may arrange blood tests (such as electrolytes, creatinine, and BUN) before and/or after the procedure and consider ECG monitoring in those with significant cardiac history or on QT-prolonging medicines to help detect potential complications from the bowel preparation.

Q: How long after I start Sutab will it begin to work, and how long will the effects last?
A: Most people begin having frequent loose or watery bowel movements within a few hours of the first dose, and the effects usually continue until several hours after the second dose is completed and the colon is cleaned for the procedure.

Q: Can I crush or chew Sutab tablets to make them easier to take?
A: No, Sutab tablets are meant to be swallowed whole with water; crushing or chewing them is not recommended and may increase stomach irritation or change how they work.

Q: What should I do if I vomit or cannot finish all the Sutab tablets or water?
A: If you vomit repeatedly or cannot complete the prescribed tablets and liquids, contact your endoscopy team right away, because your colon may not be clean enough and they may adjust your instructions or the timing of your colonoscopy.

Q: How much water do I really need to drink with Sutab?
A: Each dose of 12 tablets is taken with 16 ounces of water, followed by two additional 16-ounce containers of water as directed, so you will drink a large volume of clear liquids to stay hydrated and help flush the colon.

Q: Is Sutab safe if I have kidney or heart problems?
A: People with kidney disease, heart failure, or heart rhythm problems can sometimes use Sutab but need careful evaluation and instructions from their clinician, who may recommend extra monitoring and emphasize drinking the prescribed amount of clear liquids to reduce the risk of dehydration and electrolyte changes.

Storage
Store Sutab tablets at room temperature (68°F–77°F / 20°C–25°C) in the original bottles with the caps tightly closed, protected from moisture, and out of the reach of children; do not swallow the desiccant canister inside the bottles and remove and discard it before you start taking the tablets.

Disposal
After your procedure, dispose of any unused tablets and empty bottles according to local guidance (such as medication take-back programs or, if allowed, in household trash), keep them away from children and pets until discarded, and do not flush tablets down the toilet or pour them into sinks.